215 related articles for article (PubMed ID: 36421714)
1. Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma.
Zuo D; Xiao J; An H; Chen Y; Li J; Yang X; Wang X; Ren L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421714
[TBL] [Abstract][Full Text] [Related]
2. Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker.
Hu G; Gao F; Wang G; Fang Y; Guo Y; Zhou J; Gu Y; Zhang C; Gao N; Wen Q; Qiao H
J Transl Med; 2021 Aug; 19(1):359. PubMed ID: 34412629
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA IGF2AS in Serum may be a Biomarker for Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Qi J; Li J; Sun J; Li C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850718
[TBL] [Abstract][Full Text] [Related]
5. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
6. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
7. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Song T; Wang L; Xin R; Zhang L; Tian Y
J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
[TBL] [Abstract][Full Text] [Related]
9. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
10. Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.
Liu T; Liu D; Liu R; Jiang H; Yan G; Li W; Sun L; Zhang S; Liu Y; Guo K
Sci Rep; 2017 Jan; 7():38918. PubMed ID: 28079114
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
[TBL] [Abstract][Full Text] [Related]
12. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
13. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS.
He X; Wang Y; Zhang W; Li H; Luo R; Zhou Y; Liao CL; Huang H; Lv X; Xie Z; He M
Neoplasma; 2014; 61(1):17-26. PubMed ID: 24195504
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma.
She S; Xiang Y; Yang M; Ding X; Liu X; Ma L; Liu Q; Liu B; Lu Z; Li S; Liu Y; Ran X; Xu X; Hu H; Hu P; Zhang D; Ren H; Yang Y
Int J Oncol; 2015 Aug; 47(2):543-54. PubMed ID: 26058824
[TBL] [Abstract][Full Text] [Related]
15. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Serum DNASE1L3 in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Ouyang B; Xie QQ; Huang W; Wang L; Tang S; Fu J
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739053
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
Cai X; Tang D; Chen J; Li H; Zhang P
Lab Med; 2023 May; 54(3):270-281. PubMed ID: 36219698
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P
Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
Gao G; Dong F; Xu X; Hu A; Hu Y
Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.
Wu CS; Lee TY; Chou RH; Yen CJ; Huang WC; Wu CY; Yu YL
PLoS One; 2014; 9(6):e99959. PubMed ID: 24927126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
